|
| |
|
 |
|
|
| [DISPLAY PATENT] |
| |
| |
|
|
| Application no. and date | 15790622.3 (espacenet) (Federated) (European Patent Register), 20151002 | | Patent/reg. no. and date | DK/EP 3200783, 20190731 | | Publication date | 20170809 | | Priority no. and date | GB 201417497, 20141003 | | EP pub. no. and date |
EP 3200783 20170809 | | Effective date | | | Applicant/owner | Convergence Pharmaceuticals Limited, 90 High Holborn
London WC1V 6XX, GB | | Applicant ref. no. | T6043_DK | | Inventor | MORISSET, Valerie, c/o Convergence Pharmaceuticals Limited
Maia Building
Babraham Research Campus
Cambridge
Cambridgeshire CB22 3AT, GB | | Representative | Orsnes Patent ApS, Sentvedvej 23, 5853 Ørbæk, DK | | Opponent | | | IPC Class | A61K 31/401 (2006.01) , A61P 25/02 (2006.01) , A61P 29/00 (2006.01) , C12Q 1/68 (2018.01) , C12Q 1/6883 (2018.01) | | Title | BEHANDLING AF ERYTROMELALGI | | Int. application no. | GB2015052885 | | Int. publication no. | WO2016051194 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
|
|
|
|
